Showing results (291-300 of 5,939) with videos related to
Sort By:
Pageof 594
Clinical Endocrinology|September 1, 1978
Pharmacokinetics of 1-desamino-8-D-arginine vasopressin (DDAVP) in patients with central diabetes insipidusP T Pullan, H G Burger, C I JohnstonClinical and Experimental Pharmacology & Physiology|April 1, 1987
Pharmacokinetics of angiotensin converting enzyme inhibition in tissues following oral lisinopril: studies in the rat using quantitative radioinhibitor bindingB Jackson, R Cubela, K Sakaguchi, et al.Molecular & General Genetics : MGG|November 1, 1992
SCM4, a gene that suppresses mutant cdc4 function in budding yeastS A Smith, P Kumar, I Johnston, et al.Human Reproduction (Oxford, England)|March 1, 1995
Parthenogenetic activation of human oocytes following cryopreservation using 1,2-propanediolD A Gook, S M Osborn, W I JohnstonClinical Science (London, England : 1979)|December 1, 1980
Adrenal angiotensin II receptors and vascular reactivity to angiotensin II in the rat during continuous inhibition of angiotensin converting enzymeJ A Millar, D J Casey, C I JohnstonJournal of Interferon Research|December 1, 1989
Induction of the 2-5A system by interferon and transmissible gastroenteritis virusB T Bosworth, N J MacLachlan, M I JohnstonThe Journal of Laboratory and Clinical Medicine|January 1, 1990
Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the ratB Jackson, L Franze, E Sumithran, et al.British Journal of Clinical Pharmacology|May 1, 1985
Enalapril (MK421) activation in man: importance of liver statusI Larmour, B Jackson, R Cubela, et al.Journal of Cardiovascular Pharmacology|January 1, 1986
Role of vasopressin in experimental congestive cardiac failureC I Johnston, L Arnolda, J Abrahams, et al.Clinical Science (London, England : 1979)|December 1, 1979
Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertensionP G Matthews, B P McGrath, C I JohnstonPageof 594